Condition
Treatment Outcome clinical trials and research
As of November 12, 2026, Find a Trial lists 12 Treatment Outcome clinical trials that are recruiting, at sites in 7 countries (most in China (4), Denmark (3), Netherlands (1)). 1 was first registered in the last 30 days. By phase: Phase 3 (1). There are also 12 NIH-funded research projects on Treatment Outcome, with $6.8 million in listed awards. Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 12Clinical trials
- 12NIH research projects
- 1New in 30 days
- 7Countries
Newest Treatment Outcome clinical trials
All recruiting trials (12)
-
Long-term outcomes after vacuum-induced tamponade for postpartum hemorrhage
This study will look at women who had postpartum hemorrhage treated with vacuum-induced tamponade at a Zurich hospital to see how they fared over time, including future pregnancies and fertility.
-
Flumazenil to help reduce cognitive side effects during ECT for depression
This study tests whether giving flumazenil to reverse benzodiazepine effects during electroconvulsive therapy can lower cognitive side effects without reducing treatment effectiveness in adults with depression.
-
Home-based Acute Care for Older Adults Initiated by Emergency Services
A team-based, home-delivered acute care approach for people 75+ is being studied to see if it can match the results of usual ED care in terms of care needs and mortality.
-
Observing the effects of Sacituzumab Govitecan in metastatic breast cancer
This study is testing how well Sacituzumab Govitecan works and how safe it is for people with metastatic HER-2 negative breast cancer who have already tried at least two other treatments.
-
Exploring the link between plasma sphingolipids and radiotherapy effectiveness in liver cancer
This study is trying to see if the levels of certain fats in the blood can help predict how well radiotherapy works for people with liver cancer.
-
Effect of BCG and Tislelizumab on Bladder Cancer
This study is testing if combining a vaccine called BCG with a new drug called tislelizumab can help people with intermediate and high-risk bladder cancer have fewer recurrences after surgery.
-
Using advanced MRI to improve deep brain stimulation for Parkinson's disease
This study is testing if using advanced MRI technology can help improve deep brain stimulation for people with advanced Parkinson's disease by better targeting the brain areas that control movement.
-
Identifying predictors for treatment response in major depression
This study is trying to find out what factors can help predict how well different treatments will work for people with major depression.
-
Fixation methods for ankle fractures with posterior malleolus involvement
This study is testing a new way to fix certain ankle fractures to see if it works better than the usual methods for people with these types of injuries.
-
How chronic liver diseases connect with other long-term illnesses
We will look back at hospital records to see if chronic liver diseases are linked with other systemic illnesses in adults who visited Tzu Chi gastroenterology clinics.
-
Investigating exercise therapy and soft braces for knee osteoarthritis
This study is testing whether exercise therapy and using a soft knee brace can help people with knee osteoarthritis feel less pain and improve their recovery.
-
Treatment for knee osteoarthritis using 99Tc-MDP
This study is testing a new anti-inflammatory drug called 99Tc-MDP to see if it works better than celecoxib for people with knee osteoarthritis.
NIH-funded research (12)
Early-stage science funded by the US National Institutes of Health. Most of these projects don't enroll patients, but they show what is being worked on.
-
Treatment outcomes for Chagas disease in dogs to inform human care
This grant tests whether treating early versus later in infection improves recovery and long-term health in dogs with Chagas disease, with findings intended to help people protected from or living with the disease.
-
Gut bacteria and treatment outcomes in lymphoma
Seeing whether the mix of gut bacteria relates to treatment success and immune responses in people with diffuse large B‑cell lymphoma.
-
Suicide risk interventions: comparing how much therapy and brain markers predict outcomes
A study in veterans and active-duty service members compares how different amounts of therapy, plus brain-activity clues, affect future suicide risk.
-
Improving Chagas Disease Treatment
This research explores how quickly treatment for Chagas disease can prevent heart damage and provide lasting protection.
-
Blood markers in teens to detect suicide risk and predict treatment response
Researchers are measuring tiny RNA fragments in blood exosomes to find signals of suicide risk and treatment response in adolescents.
-
Comparing different treatment approaches for preventing suicide in veterans and active duty service members
This study is looking at different types of support to help active duty service members and veterans who are at risk of suicide, comparing a quick one-time therapy session with longer treatments to see which works best for different people.
-
Investigating how gut bacteria affect lymphoma treatment outcomes and immune response
This study is looking at how the bacteria in your gut might affect how well treatment works for people with diffuse large B-cell lymphoma, and it hopes to find ways to personalize therapies based on your unique gut health.
-
Identifying blood markers for suicidal thoughts and behaviors in adolescents
This study is looking at tiny particles in the blood that might help us find specific markers for understanding suicidal thoughts and behaviors in teenagers, with the hope of improving how we predict and support those at risk.
-
Improving body image support for women in weight management programs
This study is looking at how worries about body image can impact weight loss for women, and it aims to create helpful programs that tackle these negative feelings to support healthier eating habits and better weight management.
-
Understanding how to improve treatment outcomes for Chagas disease
This study is looking at how starting treatment sooner or later for Chagas disease in dogs can help them get better and protect their hearts, and the results could help us understand how to treat the disease in people too.
-
Understanding genetic factors affecting treatment outcomes in childhood leukemia
This study is looking at how certain genetic differences can affect how well children with acute lymphoblastic leukemia respond to treatment, with the goal of finding ways to tailor therapies to help them do better.
-
Identifying DNA markers to predict treatment outcomes in multiple myeloma
This study is looking at how certain changes in your DNA found in your blood can help doctors predict how well your multiple myeloma treatment will work, so they can tailor your care to better suit your needs.
Related topics
Quick answers
How many Treatment Outcome clinical trials are recruiting right now?
12, as of November 12, 2026. 1 of them was first registered in the last 30 days. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 7 countries. The most sites are in China (4 trials), Denmark (3 trials), Netherlands (1 trial), Taiwan (1 trial), Sweden (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 3: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.